Colorectal Cancer
Thalomid Irinotecan Trial Results Reported
Published in Cancer Weekly, August 29th, 2000
Based on the data, published in a recent issue of The Lancet, clinical investigators at the University of Arkansas for Medical Sciences have concluded that additional studies of Thalomid in combination with irinotecan are warranted.
This pilot clinical trial was initiated to evaluate the combination of therapy with Thalomid and irinotecan, a commonly used chemotherapeutic drug for patients with metastatic colorectal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2000-08-29)
More Articles from Cancer Weekly
- Alternative Medicine
Many Cancer Patients Use Complementary, Alternative Therapies to Supplement Primary Treatment - Carcinogenesis
Study Points to Cell "Crisis" as Key Event in Development of Cancer in Older Adults - Glottic Carcinoma
Transoral CO2 Laser Surgery Recommended as Treatment - Head and Neck Cancer
Both Radical and Modified Radical Neck Dissection Effective Treatment for Advanced Neck Disease - Nasal Lymphomas
Murphy Staging System Not Currently Suitable for Staging Purposes - Testicular Cancer
New Agents Show Treatment Potential - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
